Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.1
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 5,560 $ 123,476,102 $ (65,698,101) $ 57,783,561
Balance, shares at Dec. 31, 2017 55,603,427      
Stock-based compensation expense 7,609,508 7,609,508
Issuance of common stock, net of issuance costs $ 150 11,235,170 11,235,320
Issuance of common stock, net of issuance costs, shares 1,500,000      
Issuance of common stock upon exercise of stock options $ 14 347,631 $ 347,645
Issuance of common stock upon exercise of stock options, shares 139,069     139,069
Issuance of common stock upon exercise of warrants $ 1 4,999 $ 5,000
Issuance of common stock upon exercise of warrants, shares 5,000      
Fair value of warrant issued in connection with Investment Agreement 6,215,225 6,215,225
Net loss (55,672,139) (55,672,139)
Balance at Dec. 31, 2018 $ 5,725 148,888,635 (121,370,240) 27,524,120
Balance, shares at Dec. 31, 2018 57,247,496      
Stock-based compensation expense 11,981,655 11,981,655
Issuance of common stock, net of issuance costs $ 620 37,718,078 37,718,698
Issuance of common stock, net of issuance costs, shares 6,198,500      
Issuance of common stock upon exercise of stock options $ 10 386,800 $ 386,810
Issuance of common stock upon exercise of stock options, shares 107,029     107,029
Issuance of common stock upon exercise of warrants $ 112 (112)
Issuance of common stock upon exercise of warrants, shares 1,119,868      
Net loss (71,453,718) (71,453,718)
Balance at Dec. 31, 2019 $ 6,467 $ 198,975,056 $ (192,823,958) $ 6,157,565
Balance, shares at Dec. 31, 2019 64,672,893